Medications for Myocardial Infarction

7 results

  • brilinta - ticagrelor tablet

    (Ticagrelor)
    Astrazeneca Pharmaceuticals Lp
    Brilinta reduces the risk of cardiovascular death, heart attack, and stroke in patients with acute coronary syndrome or prior heart attack. It also lowers the risk of first heart attack or stroke in high-risk coronary artery disease patients, and reduces stroke risk after mild ischemic stroke or high-risk TIA.
    Medication Details
    Drug Interactions

  • kerendia - finerenone tablet, film coated

    (Finerenone)
    Bayer Healthcare Pharmaceuticals Inc.
    Kerendia reduces risk of kidney disease progression, cardiovascular death, heart attack, and heart failure hospitalization in adults with chronic kidney disease and type 2 diabetes. Also indicated for cardiovascular death and heart failure events in adults with heart failure with preserved or mildly reduced ejection fraction (LVEF ≥ 40%).
    Medication Details
    Drug Interactions

  • lipitor - atorvastatin calcium tablet, film coated

    (Atorvastatin Calcium)
    Viatris Specialty Llc
    Lipitor reduces LDL cholesterol in adults and children 10+ with hyperlipidemia or familial hypercholesterolemia. It also lowers the risk of heart attack, stroke, and cardiovascular procedures in adults with coronary heart disease risk factors, type 2 diabetes, or established heart disease.
    Medication Details
    Drug Interactions

  • praluent - alirocumab injection, solution

    (Alirocumab)
    Regeneron Pharmaceuticals, Inc.
    Praluent reduces LDL cholesterol in adults with hypercholesterolemia, HeFH, or HoFH (ages 8+), and lowers the risk of major cardiovascular events—heart attack, stroke, coronary death, or unstable angina—in high-risk adults.
    Medication Details
    Drug Interactions

  • vascepa - icosapent ethyl capsule

    (Icosapent Ethyl)
    Amarin Pharma Inc.
    VASCEPA (icosapent ethyl) reduces cardiovascular event risk in adults with elevated triglycerides on statin therapy, and lowers triglyceride levels in adults with severe hypertriglyceridemia (≥ 500 mg/dL).
    Medication Details
    Drug Interactions